Neurological post‐acute sequelae of SARS‐CoV‐2 infection

M Takao, M Ohira - Psychiatry and Clinical Neurosciences, 2023 - Wiley Online Library
The novel coronavirus disease 19 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), can have two phases: acute (generally 4 weeks …

Psychological distress, depression, anxiety, and life satisfaction following COVID-19 infection: evidence from 11 UK longitudinal population studies

EJ Thompson, J Stafford, B Moltrecht… - The Lancet …, 2022 - thelancet.com
Background Evidence on associations between COVID-19 illness and mental health is
mixed. We aimed to examine whether COVID-19 is associated with deterioration in mental …

Reconsideration of antinucleocapsid IgG antibody as a marker of SARS-CoV-2 infection postvaccination for mild COVID-19 patients

S Dhakal, T Yu, A Yin, N Pisanic… - Open Forum …, 2023 - academic.oup.com
Antinucleocapsid (anti-N) immunoglobulin G antibody responses were lower in plasma and
oral fluid after severe acute respiratory syndrome coronavirus 2 infection in vaccinated …

Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV–a prospective …

LD Heftdal, L Pérez-Alós, RB Hasselbalch… - …, 2023 - thelancet.com
Background We investigated long-term durability of humoral and cellular immune responses
to third dose of BNT162b2 in people with HIV (PWH) and controls. Methods In 378 PWH with …

SARS-CoV-2 seroprevalence among Canadian blood donors: the advance of Omicron

SF O'Brien, N Caffrey, QL Yi, C Pambrun, SJ Drews - Viruses, 2022 - mdpi.com
With the emergence of the SARS-CoV-2 Omicron variant in late 2021, Canadian public
health case/contact testing was scaled back due to high infection rates with milder symptoms …

[HTML][HTML] Infection-induced SARS-CoV-2 seroprevalence among blood donors, Japan, 2022

R Kinoshita, T Arashiro, N Kitamura, S Arai… - Emerging Infectious …, 2023 - ncbi.nlm.nih.gov
A nationwide survey of SARS-CoV-2 antinucleocapsid seroprevalence among blood donors
in Japan revealed that, as of November 2022, infection-induced seroprevalence of the …

SARS‐CoV‐2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February …

EW Kagucia, AK Ziraba, J Nyagwange… - Influenza and other …, 2023 - Wiley Online Library
Background We sought to estimate SARS‐CoV‐2 antibody seroprevalence within
representative samples of the Kenyan population during the third year of the COVID‐19 …

[HTML][HTML] Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection

SS Choi, V van Unen, H Zhang, A Rustagi… - Research …, 2023 - ncbi.nlm.nih.gov
Tissue-resident immunity underlies essential host defenses against pathogens, but analysis
in humans has lacked in vitro model systems where epithelial infection and accompanying …

[HTML][HTML] SARS-CoV-2 seroprevalence in pregnant women during the first three COVID-19 waves in The Gambia

RE Janha, A Bah, H Jah, F Touray, Y Idris… - International Journal of …, 2023 - Elsevier
Objectives SARS-CoV-2 transmission in sub-Saharan Africa has probably been
underestimated. Population-based seroprevalence studies are needed to determine the …

SARS-CoV-2 infection and COVID19 vaccination across eight immune-mediated inflammatory disorders: A prospective, real-life Belgian cohort study–the BELCOMID …

J Geldof, M Truyens, J Sabino, M Ferrante… - Frontiers in …, 2023 - frontiersin.org
Background The risks and impact of COVID19 disease and vaccination in patients with
Immune Mediated Inflammatory Diseases (IMID) remain incompletely understood. IMID …